 |
|
| Blog results | Results 1 - 10 of about 25,083 for boehringer ingelheim. (0.27 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Boehringer Ingelheim Corporate Website: Human Pharmaceuticals and ... - http://www.boehringer-ingelheim.com/ | |
| 15 Nov 2009 Boehringer Ingelheim designed the eDiary For HSDD Trials to meet the FDA`s recommendation of measuring levels of desire on a daily basis, and to report the number of satisfying sexual events. The FSFI desire score - an independently ... Boehringer Ingelheim RSS-Newsfeed - http://www.boehringer-ingelheim.com/ - References [ More results from Boehringer Ingelheim RSS-Newsfeed ] |
| 19 Nov 2009 The development and publication of the EFA Book on COPD in Europe: Sharing and Caring has been funded by an educational grant from Boehringer Ingelheim and GlaxoSmithKline. It aims to: Inform policy makers (EU and national) about COPD ... PharmaNews.eu - http://www.pharmanews.eu/component/content/frontpage - References [ More results from PharmaNews.eu ] |
| 23 Nov 2009 by Chuck When it comes to R&D at Boehringer Ingelheim Vetmedica Kevin Fowler is a go to guy. He's seen here showing research labs at the BIVI facilities in St. Joseph, MO to a group of ag media. The first thing that excites Kevin after BIVI ... AgWired - http://agwired.com/ [ More results from AgWired ] |
| 21 Nov 2009 by Chuck Zimmerman With the acquisition of Ft. Dodge Animal Health products and facilities, Boehringer Ingelheim Vetmedica has really expanded their business in the dairy industry. The head of the U.S. cattle business is Colin Meyers. ... World Dairy Diary - http://www.wdexpo.org/ [ More results from World Dairy Diary ] |
| 16 Nov 2009 by BJS Flibanserin is an investigational compound being developed by Boehringer Ingelheim for the treatment of HSDD in pre-menopausal women. HSDD is a decrease or lack of sexual desire that causes distress for the patient, may put a strain on ... Science Blog - Science news straight from... - http://www.scienceblog.com/cms/frontpage1 |
| 16 Nov 2009 German firm developing female Viagra The Day, New London, Conn. From Day, The (New London, CT) (November 14, 2009) Perhaps pharmaceutical firms Pfizer Inc. and. Drugs.com - Pharma News - http://www.drugs.com/news.html [ More results from Drugs.com - Pharma News ] |
| 20 Nov 2009 Boehringer Ingelheim's once-daily 5-HT1A agonist and 5-HT2A antagonist flibanserin has demonstrated mixed results in four pivotal Phase III trials – DAISY, VIOLET, DAHLIA and ORCHID – examining the drug's effects on the number of ... Scrip News - Home - RSS - http://www.scripnews.com/home/ [ More results from Scrip News - Home - RSS ] |
| 16 Nov 2009 by The Medical Quack 16 (Bloomberg) -- Boehringer Ingelheim GmbH's desire pill, taken at bedtime for six months, boosted women's libidos and led to better sex, according to the first published evidence showing the experimental drug works. ... The Medical Quack - http://ducknetweb.blogspot.com/ [ More results from The Medical Quack ] |
| 15 Nov 2009 by admin Muse thoughts. As a clinical sexologist and muse for this Salon I like to keep you abreast of sex in the news. Especially when it can both educate and be used. The Erotic Literary Salon - http://theeroticsalon.com/ |
| 17 Nov 2009 Nov 16, 2009 - BioSante Pharmaceuticals, Inc. (NASDAQ BPAX), a specialty pharmaceutical company developing products for female sexual health, including LibiGel. Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html [ More results from Drugs.com - Clinical Trials ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
